Published on 29 Oct 2023 on Simply Wall St. via Yahoo Finance
Pleasing Signs As A Number Of Insiders Buy Candel Therapeutics Stock
Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like they did in the case of Candel Therapeutics, Inc. (NASDAQ:CADL), that sends out a positive message to the company's shareholders.
While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we would consider it foolish to ignore insider transactions altogether.
Check out our latest analysis for Candel Therapeutics